Tag | Content |
---|
EnhancerAtlas ID | HS182-13201 |
Organism | Homo sapiens |
Tissue/cell | Spleen |
Coordinate | chr2:218705780-218707810 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
E2F6 | MA0471.1 | chr2:218705958-218705969 | GGGCGGGAAGC | + | 6.02 | EWSR1-FLI1 | MA0149.1 | chr2:218707308-218707326 | CTCTCCCTCCTTCCATCC | - | 6.04 | EWSR1-FLI1 | MA0149.1 | chr2:218706053-218706071 | GGAAGGAAGGGAGGATAT | + | 6.44 | EWSR1-FLI1 | MA0149.1 | chr2:218707312-218707330 | CCCTCCTTCCATCCTGCC | - | 6.68 | EWSR1-FLI1 | MA0149.1 | chr2:218706049-218706067 | GGCAGGAAGGAAGGGAGG | + | 7.82 | EWSR1-FLI1 | MA0149.1 | chr2:218706045-218706063 | GGGAGGCAGGAAGGAAGG | + | 7.88 | ZNF263 | MA0528.1 | chr2:218705891-218705912 | AAGGGAGAAGGGGGAAGGAGA | + | 6.21 | ZNF263 | MA0528.1 | chr2:218705800-218705821 | GAAGGAAGAAGGTGGGAAAGA | + | 6.38 | ZNF263 | MA0528.1 | chr2:218706047-218706068 | GAGGCAGGAAGGAAGGGAGGA | + | 6.72 |
|
| Number of super-enhancer constituents: 17 | ID | Coordinate | Tissue/cell |
SE_00005 | chr2:218676398-218731742 | Adipose_Nuclei | SE_00853 | chr2:218705769-218706772 | Adrenal_Gland | SE_01533 | chr2:218700407-218707915 | Aorta | SE_05795 | chr2:218700443-218707204 | Brain_Hippocampus_Middle | SE_26107 | chr2:218705844-218710641 | Duodenum_Smooth_Muscle | SE_26522 | chr2:218705745-218706920 | Esophagus | SE_29627 | chr2:218705362-218706516 | Fetal_Muscle | SE_36939 | chr2:218685985-218724919 | HSMMtube | SE_40583 | chr2:218693978-218725316 | Left_Ventricle | SE_42142 | chr2:218698721-218707980 | Lung | SE_46622 | chr2:218705860-218706478 | Ovary | SE_46622 | chr2:218706490-218706989 | Ovary | SE_48080 | chr2:218698688-218725214 | Psoas_Muscle | SE_48661 | chr2:218700415-218707894 | Right_Atrium | SE_51206 | chr2:218689199-218725234 | Skeletal_Muscle | SE_53299 | chr2:218700459-218707055 | Spleen | SE_54481 | chr2:218694206-218712678 | Stomach_Smooth_Muscle |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| Number: 2 | ID | Chromosome | Start | End |
GH02I217835 | chr2 | 218699857 | 218706417 | GH02I217841 | chr2 | 218706491 | 218706989 |
|
Enhancer Sequence | AGAGGAAAAG ACAGAGGAGA GAAGGAAGAA GGTGGGAAAG ATTTGGAAGG AATAGCACAT 60 GAAGAAGGAG TGAAAAGAAA CTGATGCTCA AAAGTGGGCC AAAGAGCTGG AAAGGGAGAA 120 GGGGGAAGGA GAGCCACCCA CCAGAGAGGG AGGAAGATTG GAGCCGGTGG AGAGGAGGGG 180 GCGGGAAGCT GCCACTGTGT CCGATGCCCT GCAGCCTGGC GTTGTACGCT GCCCACCCCC 240 CACCCCAGGG GAGCCAGCAG GGAGTGGGAG GCAGGAAGGA AGGGAGGATA TGGGGCAAGG 300 CAGGCACCCC ACCAACAGCA CAGGGAACAG ATGGACATGG GAAACACAGA GAGTGCAGGG 360 GACGGGGCAT TAAACAGGAC AAAACACAAC AAAAACAAAG AGAAAATCAA GATTAGTTGG 420 TGTTCTGACT CTGGTATCTG GGCACACACT GGAGGGAGGT GGGGAAGGTA TCAGACAGGA 480 AGAGAGGGGG ATCCAAGGTC CTGCTTCTCC AAGAGGCAGA TGGACCTCCT GCTGGCCAGC 540 ACCACAGCGT TTCCCTCTCT TCTAACCCCA GGGTGGAAGC AGAGGTGCCA TCGTGGGACC 600 AGGAGAATTC ACGCATCCCT CACCTGCTCC CATAGGCAGC AGGCCTGTCC CTGGACCACC 660 CATCTTTTCC TGGGCACCTG CCTCTCCCTG GACCCAGGTA ACACACCCAG CCTGAGCCCA 720 AGGGTCACCC TCTCTCACAC CCTGGCTCCT TACCACAGCC ATCTGAGTGA TCCTCTTTCC 780 TGGGGAACCC CTTGTGCTTT TCTGCTCTGG CCCCCAGCTT CTGGTCATCA CCAGAAAAGT 840 CCTTAAGATG AACCTTCTCA GATGCACTAG AAGGACCTGC TATGTTATCC TTTCCTTGCC 900 CCTTGTTGAC TTCTAACCCA CCTTCACACC ACAGGGGCCA CAGGAGTGGC CAACATTGCC 960 CCTGCCCTGG CCCCCAGAGT TCAAGCTATG TTACCTTTCC TCTCCTTCAC AAGCTGCTCC 1020 ATGCCAGTTC CTATGCTGGT TCCCTCCTCC TGTCTGTAGC CTTGGAATGT GGGAGGTTCC 1080 AGGACTCCAT CCTTGGGACC TCTCCTTACC TGTCCTCAAC CCCTCGGTGA CATTGCCCAG 1140 TGCTATGCTT AATCTGGTAT GTACACGTCA ACAATTCCCA TATCTCTAAG TTCCAGCCTC 1200 TTCTCCTTAA ACTCCTGACT CATTTATCCA ACCACTGCAG ATGTTTCATG GTCATCTCAA 1260 ACTTAATGTG TCCAAAAGTC ATGTTTCTAG TGTTCCCCTG AAACTGCTCT TCATAAATTG 1320 TTACCCATCT CAATAAAGAG CAACTCCATT CTTTAGTTGC TCAGGCCCCA GACCTAAGCG 1380 TTGTCTCTGA CTTTTCTCTT TCTCTCTCAT TCCATGTGTA ATCTATCAGT AATCTTGTTG 1440 GCTCTACCTC CAAAATATGT CTAAAATCCG AGCACTTCTC CCCTTTCCAT GGCCACTGCC 1500 CAGATCAATA GCAGCAGCCA CCTAACTGCT CTCCCTCCTT CCATCCTGCC CACCCTGGTC 1560 AATTCAGAAC AAGTCAGATG ATGTCACTCT TGGGCCCAAA TCCTTCCTAA GGCTTCTCAT 1620 GCCACACGGA GTAAAAGCCA CCATTCTTAC AATCACCTCA AAGACCCTCT GTAAGCTGTC 1680 CCTGTTCCCA TTTCCTCTCT GAACTTGTGT CCTGCTATGC CTCCCTTGAT CACTCTACTC 1740 CAGCCATGCC AGGCACACTC CTGCCTCGGG GCCTCTGCAC TTGTTGCTCC ATGGGGCTCA 1800 TCTCTCGCTG CCCAGCCCTG ATCATCCCAT GTAAAGTGCA GCCAGCCACC CCCTACCTCT 1860 CACTGCTTTA TCTCAATGGC ACGTATCACC TATCTGACAT ATCCTATGTA TATGTGCTTA 1920 TTTGCTCAGT ATCCATCTCT GCTGTAAGGG CAAGGATCTT TATTTGCCAC CATTTTCACA 1980 AAGCCTAGAC TGGCAAGCAG CACCCATTAG AAGTTCATGT TGAATCGAAT 2030
|